Genes2Me Blog – CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems

Genes2Me Blog – CE IVD Approved RT-PCR POC, NGS Testing Kits Solutions Instruments Device Systems

Real Time PCR Molecular Diagnostics NGS Cancer Screening Sequencing COVID-19 Rapid Antigen Antibody Made in India Manufacturer Clinical/Whole Exome

Skip to content
Menu
  • Home
  • Visit Genes2Me

Author: Genes2Me

Established in 2016, Genes2Me is a leading molecular diagnostics company committed to transforming healthcare through innovative, high-quality in vitro diagnostic (IVD) solutions. Built on a strong foundation of scientific excellence and precision engineering, Genes2Me develops and manufactures advanced diagnostic technologies that enable accurate, reliable, and timely clinical decision-making across diverse healthcare settings worldwide. With a comprehensive and rapidly expanding portfolio, Genes2Me offers cutting-edge solutions across molecular diagnostics, including Next Generation Sequencing (NGS) clinical assays, point-of-care (POC) testing platforms, RT-PCR kits and instruments, as well as nucleic acid extraction kits and automation systems. Designed to meet the evolving needs of modern laboratories and clinicians, our products combine performance, scalability, and operational efficiency. A vast majority of Genes2Me products are CE-IVD marked, reflecting our commitment to global quality benchmarks, regulatory compliance, and uncompromising product standards. At the heart of our innovation are proprietary platforms such as OnePCR and Rapi-Q, developed to deliver rapid, multiplex, and highly sensitive molecular detection with streamlined workflows and minimal turnaround time. OnePCR integrates automated nucleic acid extraction and RT-PCR into a single, seamless workflow, enabling the detection of up to 20 targets from a single sample with exceptional precision and efficiency. The Rapi-Q series is engineered for fast, sensitive, and multiplex testing with a larger throughput, empowering healthcare providers with timely diagnostic insights that support improved patient outcomes. In genomics, Genes2Me offers one of the industry’s most comprehensive NGS clinical assay portfolios, spanning oncology, liquid biopsy, whole exome sequencing, NIPT and pharmacogenomics. Complementing this portfolio is EZY AutoPrep, our advanced automated library preparation workstation designed to optimize NGS library preparation through enhanced accuracy, reproducibility, and scalability. Our genomics ecosystem is further strengthened by CliSeq Interpreter, a cloud-based bioinformatics platform that enables accurate, flexible, and intuitive interpretation of complex genomic data, helping laboratories generate high-confidence insights with efficiency and ease. Driven by innovation, quality, and a global vision, Genes2Me continues to redefine the future of molecular diagnostics—delivering integrated solutions that advance precision medicine and improve lives worldwide.
Alzheimer Parkinson Dementia panel
Dignostic SolutionPosted onSeptember 17, 2026September 17, 2026

One gene panel. Three diagnoses sorted out. No guessing.

One gene panel. Three diagnoses sorted out. No guessing. Memories fail. There’s a tremor that refuses to go away. A word that cannot be recalled.…

Read More
blood cancer awareness
blood cancerPosted onSeptember 10, 2026September 10, 2026

From Early Detection to Deeper Understanding: The Changing Landscape of Blood Cancer

Blood cancer is more than a diagnosis. But how much do we really know about what lies beneath it? Recognizing the signs and seeking timely…

Read More
FOCUS Lung NGS Assay
NGS AssaysPosted onSeptember 5, 2026September 5, 2026

Decoding Lung Cancer: Precision Genomics with FOCUS Lung & CliSeq

A tumour sample may look like a small piece of tissue, but from a genomic point of view, it contains a large amount of information.…

Read More
Real-Time PCR System
RT-PCR IVD SolutionsPosted onAugust 17, 2026August 18, 2026

Advanced by Nature. Flexible by Design. Meet the RapiCycler 96 — Real-Time PCR System

Molecular diagnostic instrumentation has come a long way, from first-generation thermal cyclers to today’s sleek, software-driven platforms. Every so often, a system comes along that…

Read More
Dignostic SolutionPosted onJuly 25, 2026July 25, 2026

From Reads to Reporting: Solving the NGS Bottleneck with CliSeq Interpreter

In the rapidly evolving landscape of clinical genomics, next-generation sequencing (NGS) has achieved remarkable milestones on the wet-lab side. High-precision, target-enriched panels—such as the Genes2Me…

Read More
PCRPosted onJuly 16, 2026July 25, 2026

Beyond Fever: Why Precision Molecular Diagnostics Are Redefining the Fight Against Vector-Borne Diseases

Every year, millions of people across the globe develop a fever with one pressing question: What is causing it? In regions where vector-borne diseases are…

Read More
PanCan CGP Assay
Next Generation SequencingPosted onJuly 10, 2026July 25, 2026

One Test. Every Biomarker. Every Solid Tumor PanCan CGP Assay

Cancer is no longer defined solely by its tissue of origin—it is driven by a complex network of genomic alterations that determine disease progression, therapeutic…

Read More
TB Diagnostics NGS
Dignostic SolutionPosted onJuly 2, 2026

Transforming TB Diagnostics with NGS: Enabling Rapid Detection and Drug-Resistant TB Management with Precision Genomics

Tuberculosis (TB), driven by the Mycobacterium tuberculosis complex (MTBC), remains the world’s leading infectious killer. Despite sustained global control efforts, TB remains a major public…

Read More
Dignostic SolutionPosted onJune 12, 2026June 12, 2026

OncoCheck: Advancing Precision Oncology Through Genomic Insights

Cancer remains one of the world’s leading health challenges, accounting for millions of new diagnoses every year. While traditional diagnostic approaches rely heavily on histopathology…

Read More
BCR-ABL Testing Solution
DiagnosticsPosted onJune 6, 2026June 6, 2026

Detect, Differentiate, Quantify: A Complete Approach to BCR-ABL Testing

Cancer is one of the leading health challenges worldwide. Among the many forms of cancer, leukemia remains one of the most complex diseases to diagnose…

Read More

Posts navigation

Page 1 Page 2 … Page 7 Next Page

Please enable JavaScript in your browser to complete this form.
Name *
Loading

Recent Posts

  • One gene panel. Three diagnoses sorted out. No guessing.
  • From Early Detection to Deeper Understanding: The Changing Landscape of Blood Cancer
  • Decoding Lung Cancer: Precision Genomics with FOCUS Lung & CliSeq
  • Advanced by Nature. Flexible by Design. Meet the RapiCycler 96 — Real-Time PCR System
  • From Reads to Reporting: Solving the NGS Bottleneck with CliSeq Interpreter

Categories

  • Antibody Test
  • Awareness Month
  • blood cancer
  • BRCA Gene Testing
  • COVID Antibody Test
  • COVID-19 RT PCR Test
  • COVID-19 Testing Kit
  • CYSTIC FIBROSIS
  • Diagnostics
  • Dignostic Solution
  • DNA RNA Solutions
  • Exome Sequencing
  • Extraction Solution
  • Genes2Health
  • Genetic Testing
  • Hepatitis
  • Manufacturing
  • Microarray
  • Mother and Child Care
  • Newborn Screening
  • Next Generation Sequencing
  • NGS Assays
  • NIPT
  • Oncology
  • PCR
  • Personalized Genomics
  • Point of Care Solution
  • Real Time PCR Solutions
  • RT-PCR IVD Solutions
  • RT-PCR Kit
  • TB Diagnostics NGS
  • Whole Exome
© Copyright 2020 – Genes2Me
Allium Theme by TemplateLens ⋅ Powered by WordPress